🇺🇸 FDA
Patent

US 11326182

Compositions for the treatment of disease

granted A61KA61K48/00

Quick answer

US patent 11326182 (Compositions for the treatment of disease) held by VOYAGER THERAPEUTICS, INC. expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K48/00